所属栏目：SCI期刊 发布时间：2023-03-30浏览量:1546
药学一区二区的SCI杂志有哪些？药学类的SCI杂志有很多的，SCI期刊根据影响因子的高低划分为一区、二区、三区、四区，分区不同影响因子也是不同的。SCI杂志的一区、二区期刊属于学术水平比较高的，对文章的要求也比较高。发表SCI文章之前要根据要求选择符合的刊物投稿，接下来，详细的推荐四本药学类SCI期刊，仅供参考。
一区
1、ACTA PHARMACOLOGICA SINICA
学科领域：
大类：医学
小类：化学：综合
中科院分区：1区
期刊简介：APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.
2、DRUGS
学科领域：
大类：医学
小类：药学
中科院分区：1区
期刊简介：Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
二区：
1、BIODRUGS
学科领域：
大类：医学
小类：药学
中科院分区：2区
期刊简介：An essential resource for R&D professionals and clinicians with an interest in biologic therapies.
BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.
2、CNS DRUGS
学科领域：
大类：医学
小类：药学
中科院分区：2区
期刊简介：CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:
- Overviews of contentious or emerging issues.
- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.
- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.
- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.